Home About Us Products Clinical Trials News Investors Contact Investor Centre We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need. You can subscribe to our press releases by clicking here. 93.5p -1.50p at 02-12-2021 10:52:00 15 minute delayed share price from London Stock Exchange provided by Euroland. Latest RNS View all Interim Results CTX-iPSC platform data shows commerical potential Notice of Results Latest Reports View all ReNeuron Group plc – Annual Report 2021 ReNeuron Group plc Interim Statement 2020 ReNeuron Group plc Annual Report 2020 Presentations View all 2021 Interim Results and Business Update Corporate Presentation Preliminary results presentation for the year ended 31 March 2021 Latest News View all Interim Results for the six months ended 30 September 2021 New CTX-iPSC platform data shows potential in Peripheral Nerve Repair Notice of Results – Investor presentation Section: Investors The financial year in review to March 2021 The financial year in review to March 2020 The financial year in review to March 2019 Email alerts General Meetings Investor Centre Corporate Governance Share Price Information Analyst Research Advisors Webcasts and Presentations Financial Reports Financial Calendar Major Shareholdings RNS Notifications Documents and Circulars Declarations Our Products Read more Our Technologies Read more Subscribe here for our Press Releases: The information collected will be used to send you the information you have requested and to provide information that may be useful to you. ReNeuron may share non-personal aggregate statistics (group) data about ReNeuron’s website visitors with partners or other parties. However, ReNeuron will not sell or share any information about individual users. Please ensure you have read the full contents of our Privacy Notice before continuing. If you agree to your information being used in this way, please tick the box: I agree Click here © ReNeuron Group plc 2021 All rights reserved Website design by Carr Kamasa Design Privacy Notice Disclaimer